Regional haemodynamic effects of dopamine and its prodrugs l-dopa and gludopa in the rat and in the glycerol-treated rat as a model for acute renal failure-Reference-Cited by-同舟云学术

Regional haemodynamic effects of dopamine and its prodrugs l-dopa and gludopa in the rat and in the glycerol-treated rat as a model for acute renal failure

Published:1994-04 Issue:4 Volume:111 Page:1117-1122
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Drieman J.C.,Kan F.J.P.M.,Thijssen H.H.W.,Essen H.,Smits J.F.M.,Boudier H.A.J. Struijker

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1476-5381.1994.tb14860.x/fullpdf

Reference32 articles.

1. Metabolism and vascular effects of gamma-L-glutamyl-L-dopa on the isolated rat kidney;BARTHELMEBS;Kidney Int.,1990

2. Effects of dopamine prodrugs and fenoldopam on glomerular hyperfiltration in streptozotocin-induced diabetes in rats;BARTHELMEBS;J. Cardiovasc. Pharmacol.,1991

3. The pharmacokinetics of gamma-glutamyl-l-dopa in normal and anephric rats and rats with glycerol-induced acute renal failure;BOATENG;Br. J. Pharmacol.,1990

4. Attenuation of amphotericin B nephrotoxicity in the dog by the fenoldopam prodrug, SK&F R-105058;BROOKS;J. Pharmacol. Exp. Ther.,1991

5. The pathogenesis of glycerol-induced renal tubular necrosis;CARROL;J. Path. Bact.,1965

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Annona muricata mitigates glycerol-induced nephrotoxicities in male albino rats through signaling pathways of angiotensin conversion enzyme, kidney injury molecule-1, and antioxidant properties;Scientific African;2022-07

2. Targeted γ-Secretase Inhibition To Control the Notch Pathway in Renal Diseases;Journal of Medicinal Chemistry;2015-10-12

3. Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: The Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) Trial;International Journal of Cardiology;2014-03

4. Enzyme-Activated Prodrug Strategies for Site-Selective Drug Delivery;Prodrugs and Targeted Delivery;2011-04-04

5. Enzyme-Activated Prodrug Strategies for Targeted Drug Action;Targeted Delivery of Small and Macromolecular Drugs;2010-05-12